Advertisement
open access
Medical Conferences
Conference Reports
Conference Proceedings
Specialties
Cardiology
Dermatology
Endocrinology
Gastroenterology
Haematology
Nephrology
Neurology
Oncology
Psychiatry
Pulmonology
Rheumatology
Urology
Multimedia
Podcast channel
Video channel
About
2024 Medicom Conference Planning
About Conference Proceedings
Webinar
Home
>
Rheumatology
>
EULAR 2020
EULAR 2020
EULAR eCongress 2020 3-6 June 2020
Read the full Report (e-book)
Table of Contents
Colophon
Table of Contents
Featured articles
EULAR 2020 Highlights Podcast
Presented By
Dr Rachel Giles, Medicom
Letter from the Editor EULAR 2020
Editor
Prof. Dennis McGonagle, University of Leeds, UK
COVID-19 and inflammatory rheumatic disease: some key issues
Presented By
Prof. G. Burmester, Charité University Hospital, Germany
Secukinumab monotherapy as efficient as adalimumab
Presented By
Prof. Iain McInnes, University of Glasgow, United Kingdom
AxSpA real-life remission rates higher on biologics
Presented By
Dr Charlotte Baert, Saint Luc University Hospital, Belgium
Olokizumab significantly improves RA features and patient-reported outcomes
Presented By
Prof. Rumen Stoilov, University Hospital St. Ivan Rilski, Bulgaria
Rheumatoid Arthritis
Preliminary findings suggest rozibafusp alfa effective and tolerable in RA
Immune-related AEs due to checkpoint inhibitors require care coordination
New nanoparticle promising future agent in RA
Presented By
Prof. Kira Astakhova, Technical University of Denmark, Denmark
Olokizumab significantly improves RA features and patient-reported outcomes
Presented By
Prof. Rumen Stoilov, University Hospital St. Ivan Rilski, Bulgaria
Low DAS at 4 months predicts sustained DMARD-free remission
Presented By
Ms Marloes Verstappen, Leiden University Medical Center, the Netherlands
Ankylosing Spondylitis
Reduced maintenance dose of certolizumab pegol can be used in axSpA
Presented By
Prof. Robert Landewé, University of Amsterdam, the Netherlands
Worse response axSpA patients to second TNFi versus first TNFi
Presented By
Dr Santiago Rodrigues-Manica, Hospital Egas Moniz, Portugal
AxSpA real-life remission rates higher on biologics
Presented By
Dr Charlotte Baert, Saint Luc University Hospital, Belgium
Certolizumab pegol reduces acute anterior uveitis in axial spondyloarthritis
Presented By
Prof. Irene van der Horst-Bruinsma, Amsterdam University Medical Center, the Netherlands
TNF-α inhibitors improve bone mineral density in AS patients
Presented By
Mark Siderius, University Medical Center Groningen; Medical Center Leeuwarden, the Netherlands
Psoriatic Arthritis
Ixekizumab shows sustained improvements in pain and fatigue at 3 years
Presented By
Prof. Ana-Maria Orbai, Johns Hopkins University School of Medicine, USA
Adalimumab added to methotrexate yields better results in PsA than methotrexate escalatio
Presented By
Dr Laura Coates, Oxford University, United Kingdom
Upadacitinib provides fast onset of improvement in psoriatic arthritis
Presented By
Prof. Iain McInnes, University of Glasgow, Scotland
Secukinumab monotherapy as efficient as adalimumab
Presented By
Prof. Iain McInnes, University of Glasgow, United Kingdom
Osteoporosis and Osteoarthritis
Higher mortality risk with tramadol versus NSAIDs for osteoarthritis patients
Presented By
Lingyi Li, University of British Columbia, Canada
Hydroxychloroquine not effective in patients with hand osteoarthritis
Presented By
Dr Claudia Kedor, Charité – Universitätsmedizin Berlin, Germany
Positive effect denosumab on fall risk
Presented By
Dr Yasser El Miedany, Darent Valley Hospital, United Kingdom
Systemic Sclerosis and Systemic Lupus Erythematosus
Anifrolumab achieves rapid and durable BICLA-response
Presented By
Prof. Eric Morand, Monash University, Australia
Subclinical myocardial involvement progresses in SSc patients
Presented By
Dr Devis Benfaremo, Università Politecnica delle Marche, Italy
Wide variation in prescription and dosing patterns for hydroxychloroquine in SLE
Composite endpoint CRESS for primary Sjögren’s syndrome
Presented By
Dr Suzanne Arends, University Medical Center Groningen, the Netherlands
COVID-19
COVID-19 and inflammatory rheumatic disease: some key issues
Presented By
Prof. G. Burmester, Charité University Hospital, Germany